Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Nipro ( (JP:8086) ) is now available.
Nipro Corporation reported a discrepancy between its financial forecasts and actual results for the six months ending September 30, 2025. Despite lower-than-expected net sales due to a decline in domestic sales of medical devices and generic medicines, the company achieved higher operating and ordinary profits, attributed to decreased unrealized profit elimination and increased interest and dividend income. The profit attributable to owners exceeded forecasts due to an extraordinary gain from a real estate transaction. The company maintains its performance forecast for the fiscal year ending March 31, 2026.
The most recent analyst rating on (JP:8086) stock is a Hold with a Yen1593.00 price target. To see the full list of analyst forecasts on Nipro stock, see the JP:8086 Stock Forecast page.
More about Nipro
Nipro Corporation operates in the healthcare industry, focusing on the production and distribution of medical devices, pharmaceutical products, and related services. The company is known for its contributions to medical technology and healthcare solutions, with a market focus on both domestic and international sectors.
YTD Price Performance: 0.07%
Average Trading Volume: 527,758
Technical Sentiment Signal: Buy
Current Market Cap: Yen240.5B
Find detailed analytics on 8086 stock on TipRanks’ Stock Analysis page.